(1R,2R,3S,5S)-methyl 3-(((benzyloxy)(phenyl)phosphoryl)oxy)-8-azabicyclo[3.2.1]octane-2-carboxylate | 148533-51-1

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 托烷生物碱
• 英文名称: (1R,2R,3S,5S)-methyl 3-(((benzyloxy)(phenyl)phosphoryl)oxy)-8-azabicyclo[3.2.1]octane-2-carboxylate
• 英文别名: methyl (1R,2R,3S,5S)-3-[phenyl(phenylmethoxy)phosphoryl]oxy-8-azabicyclo[3.2.1]octane-2-carboxylate
• CAS: 148533-51-1
• 化学式: C₂₂H₂₆NO₅P
• 分子量: 415.426
• InChiKey: FYSKBWFBKJOHLL-HFYHJHCFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  29
• 可旋转键数：
  8
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.41
• 拓扑面积：
  73.9
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  (1R,2R,3S,5S)-methyl 3-(((benzyloxy)(phenyl)phosphoryl)oxy)-8-azabicyclo[3.2.1]octane-2-carboxylate 在 palladium on activated charcoal 氢气 、 1-羟基苯并三唑 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 、 三乙胺 、 三氟乙酸 作用下， 以 乙腈 为溶剂， 生成 3-[6-[(1R,2R,3S,5S)-3-[hydroxy(phenyl)phosphoryl]oxy-2-methoxycarbonyl-8-azabicyclo[3.2.1]octan-8-yl]hexanoylamino]propanoic acid
  参考文献：
  名称：

  Cocaine catalytic antibodies: the primary importance of linker effects

  摘要：

  Current treatments for cocaine addiction are not effective. The development of a catalytic monoclonal antibody (mAb) provides a strategy for not only binding, but also degrading cocaine, which offers a broad-based therapy. Hapten design is the central element for programming antibody catalysis. The characteristics of the linker used in classic transition-state analogue phosphonate haptens were shown to be important for obtaining mAbs that hydrolyze the benzoate ester of cocaine. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00659-4
• 作为产物：
  描述：

  芽子碱盐酸盐 在 盐酸 、 三乙胺 、 lithium diisopropyl amide 、 氯甲酸-2,2,2-三氯乙酯 作用下， 反应 2.0h， 生成 (1R,2R,3S,5S)-methyl 3-(((benzyloxy)(phenyl)phosphoryl)oxy)-8-azabicyclo[3.2.1]octane-2-carboxylate
  参考文献：
  名称：

  Cocaine catalytic antibodies: the primary importance of linker effects

  摘要：

  Current treatments for cocaine addiction are not effective. The development of a catalytic monoclonal antibody (mAb) provides a strategy for not only binding, but also degrading cocaine, which offers a broad-based therapy. Hapten design is the central element for programming antibody catalysis. The characteristics of the linker used in classic transition-state analogue phosphonate haptens were shown to be important for obtaining mAbs that hydrolyze the benzoate ester of cocaine. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00659-4

文献信息

• Probing Active Cocaine Vaccination Performance through Catalytic and Noncatalytic Hapten Design
  作者：Xiaoqing Cai、Timothy Whitfield、Mark S. Hixon、Yanabel Grant、George F. Koob、Kim D. Janda

  DOI：10.1021/jm400228w

  日期：2013.5.9

  Presently, there are no FDA-approved medications to treat cocaine addiction. Active vaccination has emerged as one approach to intervene through the rapid sequestering of the circulating drug, thus terminating both psychoactive effects and drug toxicity. Herein, we report our efforts examining two complementary, but mechanistically distinct active vaccines, i.e., noncatalytic and catalytic, for cocaine treatment. A cocaine-like hapten GNE and a cocaine transition-state analogue GNT were used to generate the active vaccines, respectively. GNE-KLH (keyhole limpet hemocyannin) was found to elicit persistent high-titer, cocaine-specific antibodies and blunt cocaine-induced locomotor behaviors. Catalytic antibodies induced by GNT-KLH were also shown to produce potent titers and suppress locomotor response in mice; however, upon repeated cocaine challenges, the vaccine's protecting effects waned. In depth kinetic analysis suggested that loss of catalytic activity was due to antibody modification by cocaine. The work provides new insights for the development of active vaccines for the treatment of cocaine abuse.
• Cocaine catalytic antibodies: the primary importance of linker effects
  作者：Masayuki Matsushita、Timothy Z Hoffman、Jon A Ashley、Bin Zhou、Peter Wirsching、Kim D Janda

  DOI：10.1016/s0960-894x(00)00659-4

  日期：2001.1

  Current treatments for cocaine addiction are not effective. The development of a catalytic monoclonal antibody (mAb) provides a strategy for not only binding, but also degrading cocaine, which offers a broad-based therapy. Hapten design is the central element for programming antibody catalysis. The characteristics of the linker used in classic transition-state analogue phosphonate haptens were shown to be important for obtaining mAbs that hydrolyze the benzoate ester of cocaine. (C) 2001 Elsevier Science Ltd. All rights reserved.